[Successful treatment of second hepatoblastoma relapse--case report].

INTRODUCTION The prognosis of hepatoblastoma has changed since effective adjuvant chemotherapy had been introduced in 1980's. There is a general agreement that complete resection is the cornerstone of treatment for children with hepapatoblastoma and the only way for eventual cure. CASE REPORT We describe a boy with relapsed hepatoblastoma presenting with elevated -fetoprotein (AFP) and no visible tumor by ultrasound and computed tomography (CT). The relapse was treated with chemotherapy. Second relapse occurred shortly after therapy was completed, but this time we waited for tumor mass to appear. Combined surgery and chemotherapy resulted in remission status with 48 months of follow up. CONCLUSION Hepatoblastoma relapse without evidence of tumor is not unusual but its treatment remains controversial. Radiological investigations should be repeated until site of relapse is identified. Based on our experience it seems of no benefit to treat isolated elevation of AFP.

[1]  M. Ashraf,et al.  SUCCESSFUL TREATMENT OF MULTIFOCAL UNRESECTABLE HEPATOBLASTOMA WITH CHEMOTHERAPY ONLY , 2006, Pediatric hematology and oncology.

[2]  M. Finegold.  Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice. , 2002, Medical and pediatric oncology.

[3]  H. Mildenberger,et al.  The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. , 2002, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[4]  D. V. von Schweinitz,et al.  Pretreatment prognostic factors and treatment results in children with hepatoblastoma , 2002, Cancer.

[5]  G. Perilongo,et al.  Surgical view of the treatment of patients with hepatoblastoma , 2002, Cancer.

[6]  G. Perilongo,et al.  SIOPEL trials using preoperative chemotherapy in hepatoblastoma. , 2000, The Lancet. Oncology.

[7]  D. V. von Schweinitz,et al.  Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94 , 1999, Klinische Padiatrie.

[8]  D. V. von Schweinitz,et al.  Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. , 1997, European journal of cancer.